The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections
ثبت نشده
چکیده
1. Omeprazole (R,S)-5-methoxy-2-[[(4-methoxy-3,5-dime-thylpyridine-2-yl)methyl]sulphinyl]-1Hbenzimidazole (CAS Number 73590-58-6) is a substituted benzimidazole which inhibits gastric secretion in animals and humans. It is intended for use for treatment of gastric ulcers in horses as an oral paste containing 37% w/w omeprazole at the dose of 4 mg omeprazole/kg bw/day for 28 days, followed by an additional treatment period of 30 days at a dose of 2 mg omeprazole/kg bw/day to prevent recurrence.
منابع مشابه
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections
متن کامل
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections
متن کامل
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections
The reflection paper states in its introduction that it presents points that need to be considered and debated with the view to reconsider and modify Community legislation concerning residues of veterinary medicinal products. The goal would be to determine new means to balance consumer protection, animal health, welfare and trade requirements concerning residues of pharmacologically active subs...
متن کاملThe European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/CVMP/315/98 - FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: DEVELOPMENT PHARMACEUTICS FOR VETERINARY MEDICINAL PRODUCTS RELEASED FOR CONSULTATION BY CVMP
متن کامل
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit
متن کامل
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections
Acetylsalicylic acid is widely used in human medicine. The dose depends on the condition to be treated: the therapeutic dose for anti-inflammatory, antipyretic and analgesic indications is 300 to 900 mg/person every 4 to 6 hours, with a maximum of 4000 mg/person/day. Several long-term (sometimes life-long) low dose regimes beginning at doses of 50 mg/person are also used for several cardiovascu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002